Repurposed experimental cancer drug restores brain function in mouse models of Alzheimer’s disease

Tuesday, March 31, 2015, 12:00 p.m. NIH-supported research enables clinical trial to explore treatment for most common form of dementia Scientists have found that a compound originally developed as a cancer therapy potentially could be used to treat Alzheimer’s disease. The team demonstrated that the drug, saracatinib, restores memory loss and reverses brain problems in